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(POAF) by Hu et al. (1). 
 
Hu et al. stated in their methods that “studies that met the following criteria were included: (1) 
randomized controlled trials (RCTs) of adult … patients who underwent cardiac surgery; (2) 
patients randomly assigned to receive vitamin C or placebo … Any studies of non-randomized 
designs … were excluded” (1, p. 59). However, Hu included the study by Carnes et al. although that 
was not an RCT, instead “an age- and gender-matched control group (not receiving ascorbic acid) 
was retrospectively selected” (2, p. 3). In addition, Hu did not include the data of two so far largest 
vitamin C and POAF trials that found no effect of vitamin C against POAF and therefore remained 
unpublished, leading to publication bias (3). Hu claimed that “funnel plots showed no evidence of 
publication bias” (p. 60), but the existence of those 2 unpublished large negative trials obviously 
proves that there is publication bias. 
 
Hu et al. calculated that the effect of vitamin C on POAF was OR = 0.47. However, Altman (4) 
pointed out that “the odds ratio [OR] should not be interpreted as an approximate relative risk [RR] 
unless the events are rare in both groups (say, less than 20-30%)”. In Hu’s Fig. 2, the lowest 
incidence of POAF in the placebo groups was 19%, and 6 out of 8 studies had incidence of POAF 
over 30% in their placebo groups (1). In such a case the OR does not properly approximate RR. 
Instead, the OR can substantially exaggerate the effects for common outcomes (4). Thus, Hu’s OR = 
0.47 does not indicate that vitamin C reduced the risk of POAF by 53%. Hu should have calculated 
the effect of vitamin C on the RR scale instead.  
 
In their Fig. 4, Hu et al. stated that the standard devation (SD) of the mean duration of ICU stay in 
the vitamin C group was 24.9 hours in the trial by Colby et al. (5). However, Colby reported in their 
Table 1 and text that the SD for the duration of ICU stay was 249.9 hours in their vitamin C group, 
i.e. 10 times greater than Hu claimed. Evidently, such a big error leads to a large error in the pooled 
estimate of effect, but also generates great exaggeration of the heterogeneity between the included 
trials. Hu wrote “compared with placebo group, vitamin C administration was not associated with 
any length of stay, including in the ICU” (1, p. 60). However, I calculated that there was strong 
evidence from 10 RCTs that vitamin C shortened the ICU stay in the POAF trials by 7.4% (P = 
0.002)(3). This divergence in conclusions seems to be largely caused by Hu’s 10-fold error in the 
SD value of the Colby trial mentioned above. 
 
Although the general conclusion of Hu et al. that vitamin C has some efficacy against POAF is 
consistent with trial reports, there is very strong evidence of heterogeneity in the effect (3), even 
though Hu claimed that there was “no significant heterogeneity (I2 = 44%; P = 0.09)” (1, p. 60). 
High level heterogeneity has important implications as it guides further research. Five trials in the 
USA found no benefit, discouraging further research in the USA (3). However, positive findings in 
less wealthy countries suggest that the effect of vitamin C should be further studied in such 
countries (3). 
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